Leading national and City of Hope clinical trials in lymphoma care
Official title: Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center
Funded at Beckman Research Institute/city of Hope · NIH-11416459 · Data updated 2026-11-12
A clinician-scientist at City of Hope leads and supports national and local lymphoma clinical trials to bring new therapies to patients with Hodgkin and non-Hodgkin lymphoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $208,103 |
| NIH project number | 5R50CA285409-03 |
| Project ID | NIH-11416459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with Hodgkin or non-Hodgkin lymphoma who are eligible for NCI-sponsored clinical trials.
✕Less likely to help
Patients not eligible for specific trials or who are not offered an experimental therapy may not benefit directly.
What this research studies
This grant supports Dr. Alex Herrera, a clinician-scientist, in coordinating and promoting CTN research both across the country and at City of Hope. The effort focuses on advancing novel therapies for Hodgkin and non-Hodgkin lymphomas within a leading cancer center. Dr. Herrera holds multiple leadership roles and chairs translational and clinical trial activities to push the field forward. The program includes mentorship of junior clinicians and coordination of trials through the National Clinical Trials Network and related initiatives. Overall, it aims to accelerate access to cutting-edge treatments for lymphoma patients.
Why it matters
Potential benefit: Patients with Hodgkin and non-Hodgkin lymphoma could gain faster access to promising new therapies through robust, well-supported clinical trials.
How similar studies have gone: This initiative builds on established national lymphoma trials and governance networks with demonstrated impact in advancing care.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Herrera, Alex F. — Beckman Research Institute/city of Hope
- Study coordinator: Herrera, Alex F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.